Posaconazole Amorphous

Posaconazole Amorphous
Product Description

  • Status: DMF No.: 028314
  • Patent Expiration: Off-patent
  • Usage: Antifungal

BrightGene Bio-Medical Technology Co.,Ltd.

  • CN
  • 2015
    On CPHI since
Specifications
  • CAS Registry Number
    171228-49-2
  • Selling Points
    Quality Service
  • Supplied from
    China

BrightGene Bio-Medical Technology Co.,Ltd.

  • CN
  • 2015
    On CPHI since

More Products from BrightGene Bio-Medical Technology Co.,Ltd. (49)

  • Entecavir monohydrate

    Product Entecavir monohydrate

    Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes entecavir monohydrate. It belongs to anti-viral category. Contact us for more information. • Status: DMF No.:031949 • Patent Expiration: Off-patent • Usage:AntiHBV
  • Eribulin Mesilate

    Product Eribulin Mesilate

    • Status: Validated • Patent Expiration: US:2023.07.20 ;CN:off-patent • Usage: Oncology
  • Everolimus(2.0% BHT)

    Product Everolimus(2.0% BHT)

    • Status: DMF No.:032020 • Patent Expiration: Off-patent • Usage: Oncology
  • Fidaxomicin

    Product Fidaxomicin

    • Status: DMF No.: 028803 • Patent Expiration: US:2027.03.04; • Usage: Anti-infection
  • Fondaparinux Sodium

    Product Fondaparinux Sodium

    Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes fondaparinux sodium. It belongs to cardiovascular category. Contact us for more information.
  • Micafungin Sodium

    Product Micafungin Sodium

    • Status:  • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal
  • Telavancin Hydrochloride

    Product Telavancin Hydrochloride

    • Status: Pilot • Patent Expiration: US: 2027.1.1 • Usage: Anti-infection
  • Trabectedin

    Product Trabectedin

    • Status: Validated • Patent Expiration: ODE:2022.10.23;NCE:2020.10.23 • Usage: Oncology
  • Alvimopan

    Product Alvimopan

    • Status: Pre-validation • Patent Expiration: US:2022.11 • Usage: Intestinal Ostruction
  • Posaconazole(Form Ⅰ)

    Product Posaconazole(Form Ⅰ)

    • Status: DMF No.:032346 • Patent Expiration: Off-patent • Usage: Antifungal
  • Posaconazole(Form Ⅲ)

    Product Posaconazole(Form Ⅲ)

    • Status: DMF No.:030886 • Patent Expiration: Off-patent • Usage: Antifungal
  • Sugammadex Sodium

    Product Sugammadex Sodium

    • Status: DMF No. :033904 • Patent Expiration: US:2021.01.27; CN:2020.11.23 • Usage:Selective relaxant binding agent